|
Market Cap (5-Jun) $18,417,672 (949th) |
Close (30-Jun) $0.005 |
Volume (30-Jun) 14,697,042 |
Shortsold (2-Apr) 218 (0.00%) (630th) |
|
52w High $9.00 |
52w Low $0.300 |
P/E 14.90 |
EPS -3.21 |
MXC released this announcement to the ASX on 13 April 2023, 10:00. The announcement is marked as price sensitive, and is 2 page(s) in length and 352.17kb in size.
You can view all announcements from MXC and see how they appear on a price chart on the announcements page.
At the date of this announcement, MXC was 0.000% short sold according to ASIC data. It was ranked the 634th most shorted stock on the ASX. It is now ranked as the 630th most shorted stock on the ASX with 0.000% of total shares short sold as of the latest reported data (02 April 2024).
| Other Recent Announcements from MXC | |
|---|---|
| Details of Company Address | 30 June 2023, 17:34 |
| Company Update | 30 June 2023, 17:24 |
| Results of Meeting | 29 June 2023, 18:43 |
| Fundraise closed raising up to a total of GBP 2.09m | 13 April 2023, 10:00 |
| CannEpil now available by Named Patient Request in UK | 11 April 2023, 17:12 |
| MGC Pharma Investor Presentation April 2023 | 11 April 2023, 17:00 |
| Funding Commitments Received for GBP 1.8m | 11 April 2023, 16:51 |
You must be logged in to post a reply.
MGC Pharmaceuticals 